The Serum Institute of India said it plans to manufacture 20,000 to 30,000 doses of an experimental Ebola vaccine by the end of November for use in trials against an outbreak in Uganda. The response to Uganda’s outbreak has been blunted by the absence of a proven vaccine against the …
Read More »